RSV

Moderna stock gains as RSV shot endorsed in EU (NASDAQ:MRNA)

Maddie Meyer/Getty Images News Moderna (NASDAQ:MRNA) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed mRESVIA, its vaccine targeted at the respiratory syncytial virus (RSV). Issuing a so-called positive opinion, EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended grantingContinue Reading

GSK, Pfizer decline as CDC advisors recommend narrower age range for RSV shots (NYSE:GSK)

In: Finance

Hailshadow GSK (NYSE:GSK) and Pfizer (NYSE:PFE) both declined in Wednesday trading after the CDC’s Advisory Committee on Immunization Practices recommended an age range for respiratory syncytial virus (RSV) vaccines that wasn’t as broad as drugmakers would have liked. GSK closed down ~3.6%, while Pfizer lost 2%. The panel voted thatContinue Reading

Moderna stock gains as RSV shot endorsed in EU (NASDAQ:MRNA)

Generative AI for agriculture: How Agmatix is improving agriculture with Amazon Bedrock | Amazon Web Services

Generate financial industry-specific insights using generative AI and in-context fine-tuning | Amazon Web Services